During a press conference on February 13, PhilHealth-10 Regional Vice President Delio Aseron II said the anniversary represents not only three decades of service but also a period of institutional ...

Comprehensive phosphorus management preserves residual renal function, considers dialysis modality, and minimizes intervention burden.

Monthly dosing reduces treatment visits while maintaining established safety and efficacy1,2 Builds on RYBREVANT FASPRO FDA approval to deliver the simplest and fastest ...

The lead scientist at the centre of a controversial cardiac study performed on dogs is defending the importance of his work for the first time since his London, Ont. lab was shut ...

Microsize brings over thirty years of expertise in specialized particle size engineering for the pharmaceutical ...

Chief Financial Officer Ian Somaiya said the company remains encouraged by early observations from its PREVAIL cardiovascular ...

Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved a new, simplified monthly dosing schedule* for RYBREVANT FASPROtm (amivantamab and hyaluronidase-lpuj). When ...

Halozyme Therapeutics, Inc. ("Halozyme" or the "Company") today reported its financial and operating results for the full ...

Inheriting an IRA from a parent comes with a unique set of rules. Understanding them can help you make the most of the money you inherit and avoid an unpleasant surprise at tax time.